纳指生物科技ETF(513290)
动态评分： 5.70分
投资组合
| 报告日期 | 代码 | 名称 | 金额(万元) | 比例 |
| 2024-12-31 | MDGL | Madrigal Pharmaceuticals Inc | 1025.88 | 0.67% |
| 2024-12-31 | HALO | 奥洛兹美医疗 | 927.14 | 0.61% |
| 2024-12-31 | BPMC | Blueprint Medicines Corp | 844.53 | 0.55% |
| 2024-12-31 | IONS | Ionis Pharmaceuticals Inc | 841.37 | 0.55% |
| 2024-12-31 | CYTK | Cytokinetics Inc | 846.13 | 0.55% |
| 2024-12-31 | BBIO | BridgeBio Pharma Inc | 790.44 | 0.52% |
| 2024-12-31 | TEM | Tempus AI Inc-A | 784.22 | 0.51% |
| 2024-12-31 | NUVL | Nuvalent Inc-A | 782.9 | 0.51% |
| 2024-12-31 | CRNX | Crinetics Pharmaceuticals Inc | 722.74 | 0.47% |
| 2024-12-31 | ALKS | 阿尔凯默斯 | 709.28 | 0.46% |
| 2024-12-31 | KRYS | Krystal Biotech Inc | 686.72 | 0.45% |
| 2024-12-31 | ACLX | Arcellx Inc | 632.1 | 0.41% |
| 2024-12-31 | AXSM | Axsome Therapeutics Inc | 625 | 0.41% |
| 2024-12-31 | ADMA | ADMA Biologics Inc | 617.92 | 0.4% |
| 2024-12-31 | SRRK | Scholar Rock Holding Corp | 616.71 | 0.4% |
| 2024-12-31 | APLS | Apellis Pharmaceuticals Inc | 605.02 | 0.4% |
| 2024-12-31 | RARE | Ultragenyx Pharmaceutical Inc | 592.13 | 0.39% |
| 2024-12-31 | GH | Guardant Health Inc | 575.32 | 0.38% |
| 2024-12-31 | IMVT | Immunovant Inc | 554.18 | 0.36% |
| 2024-12-31 | PTCT | PTC Therapeutics Inc | 530.63 | 0.35% |
公告&资料
